Pathogenesis underlying neurological manifestations of long COVID syndrome and potential therapeutics
The development of long-term symptoms of coronavirus disease 2019 (COVID-19) more
than four weeks after primary infection, termed “long COVID” or post-acute sequela of …
than four weeks after primary infection, termed “long COVID” or post-acute sequela of …
Epidemiology, clinical presentation, pathophysiology, and management of long COVID: an update
S Su, Y Zhao, N Zeng, X Liu, Y Zheng, J Sun… - Molecular …, 2023 - nature.com
The increasing number of coronavirus disease 2019 (COVID-19) infections have highlighted
the long-term consequences of severe acute respiratory syndrome coronavirus 2 (SARS …
the long-term consequences of severe acute respiratory syndrome coronavirus 2 (SARS …
Biomarkers in long COVID-19: A systematic review
YJ Lai, SH Liu, S Manachevakul, TA Lee… - Frontiers in …, 2023 - frontiersin.org
Purpose Long COVID, also known as post-acute sequelae of COVID-19, refers to the
constellation of long-term symptoms experienced by people suffering persistent symptoms …
constellation of long-term symptoms experienced by people suffering persistent symptoms …
Generalisable long COVID subtypes: findings from the NIH N3C and RECOVER programmes
Background Stratification of patients with post-acute sequelae of SARS-CoV-2 infection
(PASC, or long COVID) would allow precision clinical management strategies. However …
(PASC, or long COVID) would allow precision clinical management strategies. However …
SARS-CoV-2 infection produces chronic pulmonary epithelial and immune cell dysfunction with fibrosis in mice
A subset of individuals who recover from coronavirus disease 2019 (COVID-19) develop
post-acute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV …
post-acute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV …
Long COVID headache
C Tana, E Bentivegna, SJ Cho, AM Harriott… - The journal of headache …, 2022 - Springer
Headache is among the most frequent symptoms persisting or newly developing after
coronavirus disease 2019 (COVID-19) as part of the so-called long COVID syndrome. The …
coronavirus disease 2019 (COVID-19) as part of the so-called long COVID syndrome. The …
Neuropsychiatric aspects of long COVID: a comprehensive review
Although some patients have persistent symptoms or develop new symptoms following
coronavirus disease 2019 (COVID‐19) infection, neuropsychiatric aspects of long COVID …
coronavirus disease 2019 (COVID‐19) infection, neuropsychiatric aspects of long COVID …
[HTML][HTML] Post-COVID syndrome
Background As defined by the WHO, the term post-COVID syndrome (PCS) embraces a
group of symptoms that can occur following the acute phase of a SARS-CoV-2 infection and …
group of symptoms that can occur following the acute phase of a SARS-CoV-2 infection and …
Long COVID and neuropsychiatric manifestations
V Efstathiou, MI Stefanou… - Experimental and …, 2022 - spandidos-publications.com
There is accumulating evidence in the literature indicating that a number of patients with
coronavirus disease 2019 (COVID‑19) may experience a range of neuropsychiatric …
coronavirus disease 2019 (COVID‑19) may experience a range of neuropsychiatric …
The potential role of ischaemia–reperfusion injury in chronic, relapsing diseases such as rheumatoid arthritis, Long COVID, and ME/CFS: evidence, mechanisms, and …
DB Kell, E Pretorius - Biochemical Journal, 2022 - portlandpress.com
Ischaemia–reperfusion (I–R) injury, initiated via bursts of reactive oxygen species produced
during the reoxygenation phase following hypoxia, is well known in a variety of acute …
during the reoxygenation phase following hypoxia, is well known in a variety of acute …